loaded celastrol into BSA nanoparticles and produced Celastrol-BSA-NPs by high-pressure homogenization technology, which can reduce lipid accumulation and improve insulin sensitivity to treat diet-induced obesity [40]. The gene discussed is INS; the disease is obesity disorder.